Cosmetic & Antioxidant Peptides

AHK-Cu vs GHK-Cu China Wholesale Buyer Guide

Research Use Only (RUO). Products and information are intended exclusively for qualified laboratory research. Not for human consumption, clinical treatment or diagnostic use.

AHK-Cu and GHK-Cu are different copper-peptide complexes. Their names differ by only one residue letter, and the catalog contains overlapping 50mg and 100mg formats. A buyer must specify both peptide identity and copper-complex attributes before comparing wholesale offers.

Lock peptide sequence and copper-complex identity

Create independent specifications for AHK-Cu and GHK-Cu, including the peptide sequence or molecular reference, copper-binding form, expected stoichiometry where applicable, target purity or composition, nominal content, quantity and RUO status. Do not allow a generic copper peptide or blue peptide label to replace identity. Require the supplier to map its SKU to the quote, COA, analytical sample, label and packing list. Similar color, category or copper content cannot prove which peptide ligand is present.

Compare 20mg, 50mg and 100mg options

The catalog lists AHK-Cu at 20mg, 50mg and 100mg and GHK-Cu at 50mg and 100mg. Record product, strength, vials, total nominal complex, content tolerance, parent lot, finished lot and price basis separately. Overlapping strengths create selection and receiving risk. Ask whether strengths share a parent lot and how filling genealogy is maintained. Require full-name labels and prohibit molecule or strength substitutions even when a supplier presents both materials as equivalent cosmetic copper peptides.

Review peptide and metal evidence together

Ask how the analytical package supports peptide identity, chromatographic purity, copper presence or content, complex stoichiometry and other buyer-defined attributes. HPLC and MS may support parts of the peptide review, while copper-related methods may address the metal component. Check sample identifiers, expected values, complete reports, methods, dates, specifications and authorization. No single color observation or generic purity result establishes the full complex composition. Evidence must link to the exact offered batch and format.

Define the quantitative-content denominator

Clarify whether a 20mg, 50mg or 100mg label refers to total copper complex, peptide ligand, total lyophilized material or another stated basis. Ask which quantitative method or filling record supports the amount and its tolerance. Keep peptide identity, purity, copper content, stoichiometry and finished-unit quantity in separate fields. This prevents price-per-milligram comparisons from mixing incompatible denominators and helps the buyer distinguish a well-defined complex from an ambiguous colored powder or formulation.

Prevent AHK and GHK label swaps

Approve labels using the full AHK-Cu or GHK-Cu name, strength, lot and RUO wording. For mixed orders, require segregated cartons or a packing list organized by molecule, strength and lot. Ask how line clearance, label issuance, filling reconciliation and warehouse picking prevent one-letter product swaps. At receipt, inspect representative labels and seals and record appearance only as an observation. Quarantine identity, strength or lot discrepancies until supported by traceable evidence and an approved quality decision.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

Frequently asked questions

What should a batch-specific peptide COA include?

It should identify the exact material and lot, list specifications, methods and results, and connect clearly to applicable analytical evidence.

Does HPLC purity verify vial content?

No. Chromatographic purity and quantitative content are separate attributes and require suitable evidence.

Can similarly named peptides or blends be substituted?

No. A different identity, component ratio or strength requires technical review and explicit buyer approval.

Who confirms import requirements?

The importer or its broker must confirm current destination rules; supplier documents do not guarantee entry.

Request a wholesale research peptide quote

Send the exact product, strength, quantity, specification, destination, packaging and document requirements. Our B2B sourcing team will identify missing information before preparing a comparable quotation.

Request Wholesale Quote